Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease-Reference-Cited by-同舟云学术

Role of plasminogen activator inhibitor‑1 in the diagnosis and prognosis of patients with Parkinson's disease

Published:2018-04-17 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Pan Hong¹,Zhao Ying¹,Zhai Zhengping²,Zheng Jinyu³,Zhou Yong¹,Zhai Qijin¹,Cao Xiangyang¹,Tian Jisha¹,Zhao Liandong¹

Affiliation:

1. Department of Neurology, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China

2. Department of Neurology, Lianshui County People's Hospital, Huai'an, Jiangsu 223002, P.R. China

3. Department of Neurosurgery, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson’s Disease;Medical Principles and Practice;2024-08-12

2. Metabolic Changes Induced by Bariatric Surgery May be Mediated by PAI-1 and PCSK9 Crosstalk;Archives of Medical Research;2024-07

3. MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients;npj Parkinson's Disease;2023-03-16

4. Extracellular protein homeostasis in neurodegenerative diseases;Nature Reviews Neurology;2023-02-24

5. Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease;International Journal of Molecular Sciences;2022-10-27